FiercePharma1d
Novo Nordisk’s chief scientific officer looks to the future of GLP-1s
GLP-1 agonists have taken the pharma world by storm, and Novo Nordisk has been at the forefront of it all thanks to ...
FierceBiotech1d
Evotec, Novo Nordisk's drug discovery accelerator debuts first 3 projects, adds 5 partners
LAB eN 2, the drug discovery accelerator launched by Evotec and Novo Nordisk in September 2023, has unveiled its first three ...
GEN2d
Novo Nordisk and Evotec Select First Three LAB eN² Drug Discovery Projects
Evotec and Novo Nordisk launched LAB eN² in September 2023 to nurture early research from academic institutions into novel therapeutics.
JD Supra2d
Novo Nordisk Faces an Increasing Number of Lawsuits Alleging Harm Caused By Wegovy
Wegovy and other GLP-1 medications have become extremely popular over the past few years. Novo Nordisk (which makes both ...
Novo Nordisk: Just The Right Price (Rating Upgrade)
Market multiples for Novo Nordisk are also attractive now, especially with a forward P/E for 2025 at 28.3x. Learn more about NVO stock here.
I'm the Danish scientist who pioneered injectable drugs like Ozempic. Here are my 3 tips for inventing blockbuster products.
Novo Nordisk's Lotte Bjerre Knudsen says her determination is a key part of the success, but she also stays humble.